Trials / Completed
CompletedNCT04253431
The Characteristics of Different Personal Lancets on Blood Volume and Perceived Pain in Patients With Diabetes Mellitus
A Single-blind, Randomized, Single-centre Study to Investigate the Characteristics of Different Personal Lancets on Blood Volume and Perceived Pain in Patients With Diabetes Mellitus
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- HTL-Strefa S.A. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
A randomized single-blind study with the use of different lancing devices equipped with personal lancets to determine and to compare the amount of capillary blood volume and perceived pain after a single lancing of the fingertip.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Droplet lancing device (HTL-Strefa S.A.) | |
| DEVICE | Microlet 2 lancing device (Bayer) | |
| DEVICE | OneTouch Delicia lancing device (LifeScan) | |
| DEVICE | ReliOn lancing device (ReliOn) | |
| DEVICE | Accu-Chek Softclix lancing device (Roche) | |
| DEVICE | BGStar lancing device (Sanofi Aventis) | |
| DEVICE | Ultra-Fine 33G lancets (BD) | |
| DEVICE | Droplet 33G lancets (HTL-Strefa S.A.) | |
| DEVICE | OneTouch Delicia Extra Fine 33G lancets (LifeScan) | |
| DEVICE | HaemoFine 33G lancets (HTL-Strefa S.A.) | |
| DEVICE | Softclix 28 G lancets (Roche) | |
| DEVICE | ReliOn Ultra-Thin Plus 33G lancets (ReliOn) | |
| DEVICE | GlucoJect Dual S lancing device (Menarini) | |
| DEVICE | Microlet 28G lancets (Bayer) | |
| DEVICE | BGStar Ultra-Thin 33G lancets (Sanofi Aventis) |
Timeline
- Start date
- 2013-08-01
- Primary completion
- 2013-08-01
- Completion
- 2013-08-01
- First posted
- 2020-02-05
- Last updated
- 2020-02-05
Source: ClinicalTrials.gov record NCT04253431. Inclusion in this directory is not an endorsement.